Document:

Exhibit 10.5

 

ADVISORY AGREEMENT

 

This ADVISORY AGREEMENT (the
 “Agreement”) is entered into as of December 22, 2021, by and between Hyperfine, Inc., a Delaware corporation
(the “Company”), and Jonathan Rothberg, PhD. (“Dr. Rothberg”).

 

WHEREAS, on and after November 26, 2021 (the
 “Effective Date”), Dr. Rothberg will serve on the Board of Directors of the Company (the “Board”),
and will serve as the non-executive Vice Chairman of the Board, in each case, subject to his election by the Company’s shareholders,
and Dr. Rothberg has also agreed to act as an adviser to the Company following the Effective Date; and

 

WHEREAS, the Company and Dr. Rothberg
desire to entire into this Agreement setting forth the terms of Dr. Rothberg’s consulting relationship with the Company and
certain other matters relating to his advisor role.

 

NOW, THEREFORE, in consideration
of the premises and the mutual covenants and agreements herein contained, the parties hereto agree as follows:

 

1.              Consulting
Services. Dr. Rothberg agrees to advise the Company’s Chief Executive Officer and the Board on strategic matters, and
to provide consulting, business development and similar services to the Company’s Chief Executive Officer and the Board relating
to the Company’s current, future and potential scientific and strategic initiatives and such other consulting services to be reasonably
requested and authorized by the Company’s Chief Executive Officer or the Board from time to time (in the aggregate, the “Services”).
Dr. Rothberg will be reasonably available to consult by phone, email or in person at the Company’s offices, or another mutually
agreeable site with Company personnel, and any dates for visits to the Company’s offices will be arranged by mutual agreement. The
term of this Agreement will commence on the Effective Date and continue until terminated as provided herein (the “Consulting
Period”). Dr. Rothberg agrees to devote that amount of time as is reasonably required by the Company for him to perform
the Services, taking into account his other business obligations as in effect from time to time. Dr. Rothberg represents that he
has the qualifications, the experience and the ability to properly perform the Services, and that he will use his best efforts to perform
the Services such that the results are satisfactory to the Company.

 

2.              Independent
Contractor. Dr. Rothberg’s relationship with the Company will be that of an independent contractor and not that of
an employee. Dr. Rothberg will be solely responsible for determining the method, details and means of performing the Services. Dr. Rothberg
will have no authority to enter into contracts that bind the Company or create obligations on the part of the Company without the prior
written authorization of the Company. Dr. Rothberg acknowledges and agrees that he will not be eligible for any benefits available
to employees of the Company. Dr. Rothberg will perform those Services that are agreed upon by and between Dr. Rothberg and the
Board and/or the Company’s Chief Executive Officer, and Dr. Rothberg will be required to report only to the Board concerning
the Services performed under this Agreement. The nature and frequency of these reports will be left to the discretion of the Board. Dr. Rothberg
will have full responsibility for applicable taxes (including withholding taxes) for all compensation paid to Dr. Rothberg under
this Agreement, and will have full responsibility for compliance with all applicable labor and employment legal requirements with respect
to Dr. Rothberg’s self-employment. Dr. Rothberg agrees to indemnify, defend and hold the Company harmless from any liability
for, or assessment of, any claims or penalties with respect to such withholding taxes and labor or employment legal requirements.

 

     

     

    

 

3.              Compensation
and Other Benefits.

 

(a)           Consulting
Fee. As compensation for the Services provided hereunder, during the Consulting Period, the Company will pay to Dr. Rothberg
a consulting fee (the “Consulting Fee”) of (i) $16,667 per month. The Consulting Fee will be paid to Dr. Rothberg
on the first business day of each month during the Consulting Period. The Company will reimburse Dr. Rothberg for his reasonable
out-of-pocket expenses incurred in connection with the provision of the Services, pursuant to the terms and conditions of applicable Company
policies and requirements.

 

(b)           Office
Space, etc. During the Consulting Period, the Company will provide Dr. Rothberg with reasonable office space at the
Company’s headquarters and access to secretarial and administrative assistance as needed so that he may perform his duties hereunder.

 

(c)           Equity
Awards. Dr. Rothberg’s restricted stock unit grant(s) under each of the Hyperfine Research, Inc. 2014 Employee,
Director and Consultant Equity Incentive Plan or the Liminal Sciences, Inc. 2021 Employee, Director and Consultant Equity Incentive
Plan (“Incentive Plans”) shall remain outstanding and administered in accordance with the terms and conditions of the
applicable Incentive Plans and RSU Grant Agreements.

 

4.              Termination.
Either party may terminate this Agreement for any reason upon giving thirty (30) days’ advance notice of such termination. In the
event of such termination of this Agreement, the Company’s only obligation will be to pay Dr. Rothberg any earned but unpaid
Consulting Fee as of the termination date. Notwithstanding the foregoing, Dr. Rothberg’s entitlements under Sections 3(c) of
this Agreement will survive the termination of this Agreement.

 

5.              Restrictive
Covenants. Dr. Rothberg hereby reaffirms and agrees to comply with the policies and procedures of the Company and its affiliates
for protecting confidential information and will never disclose to any person (except as required by applicable law or for the proper
performance of his duties and responsibilities to the Company and its affiliates), or use for his own benefit or gain, any confidential
information obtained by Dr. Rothberg incident to his association with the Company or any of its affiliates.

 

6.              Conflicts
with this Agreement. Dr. Rothberg represents and warrants that he is not under any pre-existing obligation in conflict or
in any way inconsistent with the provisions of this Agreement. Dr. Rothberg represents and warrants that Dr. Rothberg’s
performance of all the terms of this Agreement will not breach any agreement to keep in confidence proprietary information acquired by
Dr. Rothberg in confidence or in trust prior to commencement of this Agreement. Dr. Rothberg warrants that Dr. Rothberg
has the right to disclose and/or or use all ideas, processes, techniques and other information, if any, which Dr. Rothberg has gained
from third parties, and which Dr. Rothberg discloses to the Company or uses in the course of performance of this Agreement, without
liability to such third parties. Notwithstanding the foregoing, Dr. Rothberg agrees that he will not bundle with or incorporate into
any deliveries provided to the Company herewith any third party products, ideas, processes, or other techniques, without the express,
written prior approval of the Company. Dr. Rothberg represents and warrants that he has not granted and will not grant any rights
or licenses to any intellectual property or technology that would conflict with his obligations under this Agreement. Dr. Rothberg
will not knowingly infringe upon any copyright, patent, trade secret or other property right of any former client, employer or third party
in the performance of the Services required by this Agreement.

 

    2

     

    

 

7.              Section 409A.
This Agreement is intended to comply with, or be exempt from, the requirements of Section 409A of the Internal Revenue Code of
1986, as amended, and shall be construed consistent with such intent. Notwithstanding the foregoing, in no event shall the Company have
any liability relating to the failure or alleged failure of any payment or benefit under this Agreement to comply with, or be exempt from,
the requirements of Section 409A.

 

8.              Miscellaneous.

 

(a)           Entire
Agreement. This Agreement constitutes the sole agreement of the parties and supersedes all oral negotiations and prior writings
with respect to the subject matter hereof.

 

(b)           Amendments
and Waivers.  Any term of this Agreement may be amended or waived only with the written consent of the parties.

 

(c)           Choice
of Law. The validity, interpretation, construction and performance of this Agreement will be governed by the laws of the State
of Connecticut, without giving effect to the principles of conflict of laws.

 

(d)           Severability.
If one or more provisions of this Agreement are held to be unenforceable under applicable law, such portion will be deemed to be modified
or altered to the extent necessary to conform thereto or, if that is not possible, to be omitted from this Agreement. The invalidity of
any such portion will not affect the force, effect, and validity of the remaining portion hereof.

 

(e)           Counterparts.
This Agreement may be executed in counterparts, each of which will be deemed an original, but all of which together will constitute one
and the same instrument.

 

(f)            Successors.
This Agreement is personal to Dr. Rothberg and, without the prior written consent of the Company, will not be assignable by Dr. Rothberg
otherwise than by will or the laws of descent and distribution. This Agreement will inure to the benefit of and be enforceable by Dr. Rothberg’s
legal representatives. This Agreement will inure to the benefit of and be binding upon the Company and its successors and assigns. As
used in this Agreement, “the Company” will mean both the Company as defined above and any such successor that assumes and
agrees to perform this Agreement, by operation of law or otherwise.

 

(g)           Advice
of Counsel. EACH PARTY ACKNOWLEDGES THAT, IN EXECUTING THIS AGREEMENT, SUCH PARTY HAS HAD THE OPPORTUNITY TO SEEK THE ADVICE
OF INDEPENDENT LEGAL COUNSEL, AND HAS READ AND UNDERSTOOD ALL OF THE TERMS AND PROVISIONS OF THIS AGREEMENT. THIS AGREEMENT SHALL NOT
BE CONSTRUED AGAINST ANY PARTY BY REASON OF THE DRAFTING OR PREPARATION HEREOF.

 

[Remainder of page intentionally left blank.]

 

    3

     

    

 

This Agreement has been executed
as a sealed instrument by the Company, by its duly authorized representative and by Dr. Rothberg.

 

	 	 	HYPERFINE, INC.
	 	 	 
	 	 	By: 	/s/ Dave Scott           
	 	 	 
	 	 	Name:	Dave Scott          
	 	 	 
	 	 	Title:	Chief Executive Officer              
	 	 	  
	 	 	 
	 	 	JONATHAN
    ROTHBERG, PH.D.
	 	 	 
	 	 	 
	 	 	/s/
    Jonathan Rothberg
	 	 	Signature

 

	 	 	Address:Exhibit 10.13

 

Hyperfine, Inc.

EXECUTIVE SEVERANCE PLAN

 

PLAN DOCUMENT AND SUMMARY PLAN DESCRIPTION

 

Effective as of December 22, 2021

 

1.             Establishment
of Plan. Hyperfine, Inc. (the “Company”), hereby establishes an unfunded severance benefits plan (this
 “Plan”) that is intended to be a welfare benefit plan within the meaning of Section 3(1) of ERISA. This Plan
is in effect for Participants who experience certain terminations of employment occurring after the Effective Date and before the termination
of this Plan. This Plan supersedes any and all (i) severance plans and separation policies applying to Participants that may have
been in effect before the Effective Date with respect to any termination that would, under the terms of this Plan, constitute a termination
by the Company without Cause or by Participant for Good Reason, and (ii) the provisions of any agreements between any Participant
and the Company that provide for severance payments and benefits.

 

2.             Purpose.
The purpose of this Plan is to establish the conditions under which Participants will receive the severance payments and benefits described
herein if their employment with the Company (or its successor in a Change in Control (as defined below)) terminates under the circumstances
specified herein. The severance payments and benefits paid under this Plan are intended to assist employees in making a transition to
new employment and are not intended to be a reward for prior service with the Company.

 

3.             Definitions.
For purposes of this Plan:

 

(a)            “Base
Salary” shall mean, for any Participant, such Participant’s base salary as in effect immediately before a Participant’s
termination of employment (or immediately prior to the effective date of a Change in Control, if greater) and exclusive of any bonuses,
 “adders,” any other form of premium pay, or other forms of compensation.

 

(b)            “Board”
shall mean the Board of Directors of the Company.

 

(c)            “Cause”
shall mean Participant’s: (i) willful misconduct or gross negligence in the performance of Participant’s duties; (ii) refusal
to follow the lawful directions of the Company employee to whom the Participant reports; (iii) breach of a fiduciary duty owed to
the Company; (iv) fraud, embezzlement or other material dishonesty with respect to the Company; (v) violation of applicable
federal, state or local law or regulation governing the Company’s business; (vi) commission, conviction, plea of nolo contendere,
guilty plea, or confession to a crime based upon an act of fraud, embezzlement or dishonesty or to a felony; (vii) habitual abuse
of alcohol or any controlled substance or reporting to work under the influence of alcohol or any controlled substance (other than a controlled
substance that Participant is properly taking under a current prescription); (viii) misappropriation (or attempted misappropriation)
by Participant any material assets or business opportunities of the Company or any of its subsidiaries or affiliates; (ix) a material
failure to comply with the Company’s written policies or rules, as they may be in effect from time to time during Participant’s
employment, including policies and rules prohibiting discrimination or harassment; or (x) a material breach of Participant’s
employment agreement or offer letter, the Non-Competition, Confidentiality and Intellectual Property Agreement or any other written agreement
between the Company or one of its subsidiaries and Participant, provided that Participant will have 30 days after notice from the Company
to cure a failure or a breach under (ii), (ix) or (x), if curable.

 

(d)            “Change
in Control” shall mean the occurrence of any of the following events:

 

(i) any person or group of persons
(other than the Company or its affiliates) becomes the owner, directly or indirectly, of securities of the Company representing more than
50% of the combined voting power of the Company’s then outstanding voting securities (the “Outstanding Company Voting Securities”)
(but excluding any bona fide financing event in which securities are acquired directly from the Company); or

 

    

     

    

 

(ii) the consummation of a merger
or consolidation of the Company with any other corporation, other than a merger or consolidation (i) that results in the Outstanding
Company Voting Securities immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into
voting securities of the surviving entity) at least 50% of the combined voting power of the Outstanding Company Voting Securities (or
such surviving entity or, if the Company or the entity surviving such merger is then a subsidiary, the ultimate parent thereof) outstanding
immediately after such merger or consolidation, or (ii) immediately following which the individuals who comprise the Board immediately
prior thereto constitute at least a majority of the Board of the entity surviving such merger or consolidation or, if the Company or the
entity surviving such merger is then a subsidiary, the ultimate parent thereof; or

 

(iii) the sale or disposition by
the Company of all or substantially all of the Company’s assets, other than (i) a sale or disposition by the Company of all
or substantially all of the Company’s assets to an entity, at least 50% of the combined voting power of the voting securities of
which are owned directly or indirectly by stockholders of the Company following the completion of such transaction in substantially the
same proportions as their ownership of the Company immediately prior to such sale or (ii) a sale or disposition of all or substantially
all of the Company’s assets immediately following which the individuals who comprise the Board immediately prior thereto constitute
at least a majority of the board of directors of the entity to which such assets are sold or disposed or, if such entity is a subsidiary,
the ultimate parent thereof;

 

(iv) provided that with respect to
Sections (i), (ii) and (iii) above, a transaction or series of integrated transactions will not be deemed a Change in Control
(A) unless the transaction qualifies as a change in control within the meaning of Section 409A of the Code, or (B) if following
the conclusion of the transaction or series of integrated transactions, the holders of the Company’s Class B Common Stock immediately
prior to such transaction or series of transactions continue to have substantially the same proportionate voting power in an entity which
owns all or substantially all of the assets of the Company immediately following such transaction or series of transactions.

 

(e)        
     “Change in Control Period” means: (i) the twelve (12) month period beginning on
the date of a Change in Control.

 

(f)             “COBRA”
shall mean the Consolidated Omnibus Budget Reconciliation Act.

 

(g)            “Code”
shall mean the Internal Revenue Code of 1986, as amended.

 

(h)            “Company”
shall mean Hyperfine, Inc. or, following a Change in Control, any successor thereto.

 

(i)              “Effective
Date” shall mean December 22, 2021.

 

    2

     

    

 

(j)              “Eligible
Employee” shall mean: all employees with the title of Vice President, including Executive Vice President, Senior Vice President
and Vice President.

 

(k)             “ERISA”
shall mean the Employee Retirement Income Security Act of 1974, as amended.

 

(l)              “Good
Reason” shall mean the occurrence of any of the following events without Participant’s consent: (i) a material reduction
of Participant’s Base Salary as in effect immediately prior to the reduction; (ii) a material reduction in Participant’s
authority, duties or responsibilities, provided however, following a Change in Control, a change in job title or reporting relationship
without a reduction in Participant’s Base Salary will not constitute Good Reason; (iii) relocation of the offices at which
Participant is required to work to a location that would increase Participant’s one-way commute by more than 50 miles; provided
that, within 30 days of the first occurrence of the event that Participant believes constitutes Good Reason, Participant notifies the
Company in a writing of the event, the Company fails to correct the act or omission within 30 days after receiving Participant’s
written notice and Participant actually terminates his or her employment within 60 days after the date the Company receives Participant’s
notice.

 

(m)            “Participant”
shall mean the Eligible Employees employed by the Company from time to time.

 

(n)            “Plan
Administrator” shall have the meaning set forth in Section 14 hereof.

 

4.             Severance
Not in Connection with a Change in Control. If the Company terminates Participant’s employment without Cause at any time
other than during a Change in Control Period, subject to the provisions of Section 6 and 7, Participant shall be eligible to receive
the following payments and benefits (collectively, the “Severance Package”):

 

(a)            Participant
shall be entitled to receive an amount equal to the product of (the “Normal Severance”): (i) the Normal Multiplier,
as determined under Exhibit A based on Participant’s title or role with the Company; and (ii) the Participant’s
then-current Base Salary. The Normal Severance shall be payable in the form of salary continuation in accordance with the Company’s
regular payroll schedule over the Severance Period, commencing on such date determined in accordance with Section 6 or as a lump
sum at the Company’s sole discretion. The “Severance Period” will equal the period of months equal to the product
of (A) Participant’s Normal Multiplier and (B) 12.

 

(b)            Participant
shall be entitled to continue participating in the Company’s health benefits for the Severance Period (the “Severance Benefits”),
as follows: (i) such continued benefits shall be subject to Participant’s timely election of continuation coverage under COBRA;
(ii) the Company will pay the company contribution and Participant shall be required to pay the employee contribution directly or
as a reimbursement to Participant at the Company’s sole discretion, (iii) Participant’s right to receive further Severance
Benefits shall terminate if and when Participant secures alternative health benefits from a new employer, of which Participant shall promptly
notify the Company, or if and when Participant otherwise becomes ineligible for further coverage under COBRA; and (iv) the Company
shall be required to provide the Severance Benefits only to the extent that the Company continues offering an employee health benefits
plan and to extent that the Company is not required to provide and pay for such post-termination coverage to other employees to avoid
a violation of applicable nondiscrimination requirements.

 

(c)            The
payments and benefits described in this Section 4 shall be in lieu of any other benefits or payments under any severance or similar
plan, policy or arrangement of the Company.

 

    3

     

    

 

5.             Severance
in Connection with a Change in Control. If during the Change in Control Period, the Company terminates Participant’s employment
without Cause or Participant resigns Participant’s employment with Good Reason, subject to the provisions of Section 6 and
7, Participant shall be eligible to receive the following payments and benefits (collectively, the “CIC Severance Package”):

 

(a)            Participant
shall be entitled to receive an amount equal to the product of (the “CIC Severance”): (A) the CIC Multiplier,
as determined under Exhibit A based on Participant’s title or role with the Company; and (B) the sum of Participant’s
then-current Base Salary and then-current target annual bonus opportunity. The CIC Severance shall be payable in a single lump sum, on
such date in determined accordance with Section 6.

 

(b)            Participant
shall be entitled to continue participating in the Company’s health benefits for the CIC Severance Period (the “CIC Severance
Benefits”), as follows: (i) such continued benefits shall be subject to Participant’s timely election of continuation
coverage under COBRA; (ii) the Company will pay the company contribution directly or as a reimbursement to Participant at the Company’s
sole discretion and Participant shall be required to pay the employee contribution; (iii) Participant’s right to receive further
CIC Severance Benefits shall terminate if and when Participant secures alternative health benefits from a new employer, of which Participant
shall promptly notify the Company, or if and when Participant otherwise becomes ineligible for further coverage under COBRA, whichever
occurs first; and (iv) the Company shall be required to provide the CIC Severance Benefits only to the extent that the Company continues
offering an employee health benefits plan and to extent that the Company is not required to provide and pay for such post-termination
coverage to other employees to avoid a violation of applicable nondiscrimination requirements. The “CIC Severance Period”
will equal the period of months equal to the product of (A) Participant’s CIC Multiplier and (B) 12.

 

(c)            Any
outstanding unvested equity awards held by Participant under the Company’s then-current outstanding equity incentive plan(s) will
become fully vested as of the date the termination of Participant’s employment becomes effective.

 

(d)            The
payments and benefits described in this Section 5 shall be in lieu of any other benefits or payments under any severance or similar
plan, policy or arrangement of the Company, and shall be in lieu of any benefits set forth in Section 5 of this Agreement.

 

6.             Release.
A Participant’s rights to the Severance Package or the CIC Severance Package, as applicable, is conditioned upon Participant
executing and not revoking a valid separation and general release agreement in a form provided by the Company (the “Release”),
and provided such release becomes effective and irrevocable within 60 days following termination or such shorter time period set forth
therein, releasing the Company, its subsidiaries, other affiliates and shareholders from any and all liability. Any payments or benefits
due for the period after termination and before the Release becomes effective shall be paid with the first payment after the Release becomes
effective. Notwithstanding any other provision herein, if the period during which Participant has discretion to execute or revoke the
Release straddles two calendar years, the Company shall make payments conditioned on the Release no earlier than January 1st of the
second calendar year, regardless of which year the Release becomes effective.

 

7.             Restrictive
Covenants. A Participant’s rights to the Severance Package or the CIC Severance Package, as applicable, is conditioned on
Participant’s compliance with Participant’s obligations under, as applicable: (a) Participant’s Non-Disclosure,
Non-Solicitation and Assignment Agreement; and (b) any other applicable confidentiality, invention, work product, non-disparagement,
non-competition, non-solicitation, non-interference, and/or other restrictive covenant obligations contained in any written agreement
between the Participant and the Company. In the event that Participant fails to comply with any of these obligations, the Participant’s
right to receive any additional Severance Package or CIC Severance Package payments or benefits shall cease immediately and Participant
shall promptly refund any such payments or benefits previously paid by the Company. The Company’s rights under this Section 7
shall be full recourse. The Company shall have the right to offset Participant’s obligations under this Section 7 against any
amounts otherwise owed to Participant from the Company or its affiliates.

 

    4

     

    

 

8.             Accrued
Obligations.  Notwithstanding anything to the contrary contained herein, a Participant shall be entitled to all Accrued Obligations
as of his or her termination of employment, regardless of whether he or she is eligible for severance payments or benefits under this
Plan. “Accrued Obligations” shall mean, for any Participant: (i) the portion of such Participant’s Base
Salary that has accrued prior to any termination of such Participant’s employment with the Company and has not yet been paid; (ii) the
portion of such Participant’s prior-year annual bonus that has been earned prior to any termination of such Participant’s
employment with the Company and has not yet been paid; (iii) the amount of any expenses properly incurred by such Participant on
behalf of the Company in accordance with Company policy prior to any such termination and not yet reimbursed; and (iv) the amount
of such Participant’s vacation time that has accrued prior to any such termination that has not yet been used. A Participant’s
entitlement to any other compensation or benefit under any plan of Company shall be governed by and determined in accordance with the
terms of such plans, except as otherwise specified in this Plan.

 

9.             Non-Duplication
of Benefits. Nothing in this Plan will entitle any Participant to receive duplicate benefits
in connection with any voluntary or involuntary termination of employment. A Participant’s right to receive any payments under this
Plan will be expressly conditioned upon such Participant not receiving severance payments or benefits under any other agreement, program
or arrangement.

 

10.           Death.
If a Participant dies after the date Participant commences receiving benefits and payments under the Severance Package or the CIC
Severance Package, as applicable, but before all such payments or benefits have been paid or provided, payments will be made to any beneficiary
designated by Participant prior to or in connection with such Participant’s termination or, if no such beneficiary has been designated,
to Participant’s estate.

 

11.           Withholding.
 The Company may withhold from any payment or benefit under this Plan: (a) any federal, state, or local income or payroll taxes
required by law to be withheld with respect to such payment; (b) such sum as the Company may reasonably estimate is necessary to
cover any taxes for which the Company may be liable and which may be assessed with regard to such payment; and (c) such other amounts
as appropriately may be withheld under the Company’s payroll policies and procedures from time to time in effect.

 

12.           Section 409A.
 It is expected that the payments and benefits provided under this Plan will be exempt from the application of Section 409A of
the Code, and the guidance issued thereunder (“Section 409A”). This Plan shall be interpreted consistent with
this intent to the maximum extent permitted and generally, with the provisions of Section 409A. A termination of employment shall
not be deemed to have occurred for purposes of any provision of this Plan providing for the payment of any amounts or benefits upon or
following a termination of employment (which amounts or benefits constitute nonqualified deferred compensation within the meaning of Section 409A)
unless such termination is also a “separation from service” within the meaning of Section 409A and, for purposes of any
such provision of this Plan, references to a “termination,” “termination of employment” or like terms shall mean
 “separation from service”. Neither Participant nor the Company shall have the right to accelerate or defer the delivery of
any payment or benefit except to the extent specifically permitted or required by Section 409A. Notwithstanding the foregoing, to
the extent the severance payments or benefits under this Plan are subject to Section 409A, the following rules shall apply with
respect to distribution of the payments and benefits, if any, to be provided to Participants under this Plan:

 

(a)             Each
installment of the payments and benefits provided under this Plan will be treated as a separate “payment” for purposes of
Section 409A. Whenever a payment under this Plan specifies a payment period with reference to a number of days (e.g., “payment
shall be made within 10 days following the date of termination”), the actual date of payment within the specified period shall be
in the Company’s sole discretion. Notwithstanding any other provision of this Plan to the contrary, in no event shall any payment
under this Plan that constitutes “non-qualified deferred compensation” for purposes of Section 409A be subject to transfer,
offset, counterclaim or recoupment by any other amount unless otherwise permitted by Section 409A.

 

    5

     

    

 

(b)            Notwithstanding
any other payment provision herein to the contrary, if the Company or appropriately-related affiliates is publicly-traded and a Participant
is deemed on the date of termination to be a “specified employee” within the meaning of that term under Code Section 409A(a)(2)(B) with
respect to such entity, then each of the following shall apply:

 

(i)            With
regard to any payment that is considered “non-qualified deferred compensation” under Section 409A payable on account
of a “separation from service,” such payment shall be made on the date which is the earlier of (A) the day following
the expiration of the six month period measured from the date of such “separation from service” of Participant, and (B) the
date of Participant’s death (the “Delay Period”) to the extent required under Section 409A. Upon the expiration
of the Delay Period, all payments delayed pursuant to this provision (whether otherwise payable in a single sum or in installments in
the absence of such delay) shall be paid to or for Participant in a lump sum, and all remaining payments due under this Plan shall be
paid or provided for in accordance with the normal payment dates specified herein; and

 

(ii)            To
the extent that any benefits to be provided during the Delay Period are considered “non-qualified deferred compensation” under
Section 409A payable on account of a “separation from service,” and such benefits are not otherwise exempt from Section 409A,
Participant shall pay the cost of such benefits during the Delay Period, and the Company shall reimburse Participant, to the extent that
such costs would otherwise have been paid by the Company or to the extent that such benefits would otherwise have been provided by the
Company at no cost to Participant, the Company’s share of the cost of such benefits upon expiration of the Delay Period. Any remaining
benefits shall be reimbursed or provided by the Company in accordance with the procedures specified in this Plan.

 

(c)            The
Company makes no representations or warranties and shall have no liability to any Participant or any other person, other than with respect
to payments made by the Company in violation of the provisions of this Plan, if any provisions of or payments under this Plan are determined
to constitute deferred compensation subject to Section 409A of the Code but not to satisfy the conditions of that section.

 

13.          Modified
280G Cutback.

 

(a)            To
the extent that any payment, benefit or distribution of any type to or for a Participant’s benefit by the Company or any of its
affiliates, whether paid or payable, provided or to be provided, or distributed or distributable pursuant to the terms of this Plan or
otherwise (including, without limitation, any accelerated vesting of stock options or other equity-based awards) (collectively, the “Total
Payments”) would be subject to the excise tax imposed under Section 4999 of the Code, then the Total Payments shall be
reduced (but not below zero) so that the maximum amount of the Total Payments (after reduction) shall be one dollar ($1.00) less than
the amount which would cause the Total Payments to be subject to the excise tax imposed by Section 4999 of the Code, but only if
the Total Payments so reduced result in Participant receiving a net after tax amount that exceeds the net after tax amount Participant
would receive if the Total Payments were not reduced and were instead subject to the excise tax imposed on excess parachute payments by
Section 4999 of the Code. Unless Participant shall have given prior written notice to the Company to effectuate a reduction in the
Total Payments if such a reduction is required, any such notice consistent with the requirements of Section 409A to avoid the imputation
of any tax, penalty or interest thereunder, the Company shall reduce or eliminate the Total Payments by first reducing or eliminating
any cash severance benefits (with the payments to be made furthest in the future being reduced first), then by reducing or eliminating
any accelerated vesting of stock options or similar awards, then by reducing or eliminating any accelerated vesting of restricted stock
or similar awards, then by reducing or eliminating any other remaining Total Payments. The preceding provisions of this Section shall
take precedence over the provisions of any other plan, arrangement or agreement governing Participant’s rights and entitlements
to any benefits or compensation.

 

    6

     

    

 

(b)            If
the Total Payments to a Participant are reduced in accordance with Section 14(a), as a result of the uncertainty in the application
of Section 4999 of the Code at the time of the initial reduction under Section 14(a), it is possible that Total Payments to
a Participant which will not have been made by the Company should have been made (“Underpayment”) or that Total Payments
to a Participant which were made should not have been made (“Overpayment”). If an Underpayment has occurred, the amount
of any such Underpayment shall be promptly paid by the Company to or for the benefit of such Participant. In the event of an Overpayment,
then Participant shall promptly repay to the Company the amount of any such Overpayment together with interest on such amount (at the
same rate as is applied to determine the present value of payments under Section 280G of the Code or any successor thereto), from
the date the reimbursable payment was received by such Participant to the date the same is repaid to the Company

 

14.           Plan
Administration.

 

(a)            Plan
Administrator. The Plan Administrator shall be the Board or a committee thereof designated by the Board (the “Committee”);
provided, however, that the Board or such Committee (as constituted prior to the closing of a Change in Control) may in its sole discretion
appoint a new Plan Administrator to administer this Plan following a Change in Control, which such Plan Administrator shall not be removed
or modified following a Change in Control other than at its own initiative. If such Plan Administrator designated by the Board or Committee
prior to a Change in Control ceases to serve as Plan Administrator at any point after a Change in Control but prior to the later to occur
of the first (1st) anniversary of the Change in Control or the final payment of benefits under this Plan to any Participant, then until
the later to occur of the first (1st) anniversary of the Change in Control or the final payment of benefits under this Plan to any Participant,
any such successor Plan Administrator appointed by the Board or the Committee shall be a qualified independent third party, such as a
retired judge selected by the head of the American Arbitration Association in Manhattan, an independent compensation consultant or a law
firm. The Plan Administrator shall also serve as the Named Fiduciary of this Plan under ERISA. The Plan Administrator shall be the “administrator”
within the meaning of Section 3(16) of ERISA and shall have all the responsibilities and duties contained therein. Notwithstanding
any provision of this Plan to the contrary, any employee(s) appointed to serve as Plan Administrator (whether individually or as
members of a committee) shall serve as such only for so long as he or she is an employee of the Company and shall be deemed to resign
his or her position effective as of his or her termination of employment (whether voluntary or involuntary). The Plan Administrator can
be contacted at the following address:

 

Hyperfine, Inc.

531 New Whitfield Street

Guilford, CT 06437

Attention: Chief People Officer

administrator@hyperfine.io

 

    7

     

    

 

(b)            Decisions,
Powers and Duties. The general administration of this Plan and the responsibility for carrying out its provisions shall be vested
in the Plan Administrator. The Plan Administrator shall have such powers and authority as are necessary to discharge such duties and responsibilities
which also include, but are not limited to, interpretation and construction of this Plan, the determination of all questions of fact,
including, without limit, eligibility, participation and benefits, the resolution of any ambiguities and all other related or incidental
matters, and such duties and powers of the plan administration which are not assumed from time to time by any other appropriate entity,
individual or institution. The Plan Administrator may determine from time to time, in its discretion, whether an employee of the Company
who is not an Eligible Employee shall become a Participant in this Plan, provided the Plan Administrator delivers written notice to such
employee that the employee will be a Participant in the Plan. The Plan Administrator may adopt rules and regulations of uniform applicability
in its interpretation and implementation of this Plan. The Plan Administrator may delegate any of its duties hereunder to such person
or persons from time to time as it may designate.

 

(c)            The
Plan Administrator shall discharge its duties and responsibilities and exercise its powers and authority in its sole discretion and in
accordance with the terms of the controlling legal documents and applicable law, and its actions and decisions that are not arbitrary
and capricious shall be binding on any employee, and employee’s spouse or other dependent or beneficiary and any other interested
parties whether or not in being or under a disability. The Plan Administrator is empowered, on behalf of this Plan, to engage accountants,
legal counsel and such other personnel as it deems necessary or advisable to assist it in the performance of its duties under this Plan.
The functions of any such persons engaged by the Plan Administrator shall be limited to the specified services and duties for which they
are engaged, and such persons shall have no other duties, obligations or responsibilities under this Plan. Such persons shall exercise
no discretionary authority or discretionary control respecting the management of this Plan.

 

(d)            The
Company shall promptly reimburse the Plan Administrator or the Committee for any expenses incurred in good faith in the course of carrying
out its obligations under this Plan, including, but not limited to, attorney’s fees, claims, fines, judgments, taxes, causes of
action or liability and amounts paid in settlement, actually and reasonably incurred by such Committee or Plan Administrator, unless such
expense, claim, fine, judgment, taxes, cause of action, liability or amount arose from his or her negligence, fraud or willful breach
of his or her fiduciary responsibilities under ERISA.

 

15.           Claims, Inquiries
and Appeals.

 

(a)            Applications
for Benefits and Inquiries. Any application for benefits under or inquiries about this Plan or inquiries about present or future rights
under this Plan must be submitted to the Plan Administrator in writing, as follows:

 

Plan Administrator

Hyperfine, Inc.

531 New Whitfield Street

Guilford, CT 06437

 

(b)            Denial
of Claims. In the event that any application for benefits is denied in whole or in part, the Plan Administrator must notify the applicant,
in writing, of the denial of the application, and of the applicant’s right to review the denial. The written notice of denial will
be set forth in a manner designed to be understood by the applicant, and will include specific reasons for the denial, specific references
to this Plan provision upon which the denial is based, a description of any information or material that the Plan Administrator needs
to complete the review and an explanation of this Plan’s review procedure. This written notice will be given to the applicant within
15 days after the Plan Administrator receives the application, unless special circumstances require an extension of time, in which case,
the Plan Administrator has up to an additional 15 days for processing the application. If an extension of time for processing is required,
written notice of the extension will be furnished to the applicant before the end of the initial 15-day period. This notice of extension
will describe the special circumstances necessitating the additional time and the date by which the Plan Administrator is to render his
or her decision on the application. If written notice of denial of the application for benefits is not furnished within the specified
time, the application shall be deemed to be denied. The applicant will then be permitted to appeal the denial in accordance with the review
procedure described below.

 

    8

     

    

 

(c)            Request
for a Review. Any person (or that person’s authorized representative) for whom an application for benefits is denied, in whole
or in part, may appeal the denial by submitting a request for a review to the Plan Administrator within 30 days after the application
is denied (or deemed denied). The Plan Administrator will give the applicant (or his or her representative) an opportunity to review pertinent
documents in preparing a request for a review and submit written comments, documents, records and other information relating to the claim.
A request for a review shall be in writing and shall be addressed to:

 

Plan Administrator

Hyperfine, Inc.

531 New Whitfield Street

Guilford, CT 06437

 

A request for review must set forth all of the
grounds on which it is based, all facts in support of the request and any other matters that the applicant feels are pertinent. The Plan
Administrator may require the applicant to submit additional facts, documents or other material as he or she may find necessary or appropriate
in making his or her review.

 

(d)            Decision
on Review. The Plan Administrator will act on each request for review within 15 days after receipt of the request, unless special
circumstances require an extension of time (not to exceed an additional 15 days), for processing the request for a review. If an extension
for review is required, written notice of the extension will be furnished to the applicant within the initial 15-day period. The Plan
Administrator will give prompt, written notice of his or her decision to the applicant. In the event that the Plan Administrator confirms
the denial of the application for benefits in whole or in part, the notice will outline, in a manner calculated to be understood by the
applicant, the specific Plan provisions upon which the decision is based.

 

(e)             Rules and
Procedures. The Plan Administrator may establish rules and procedures, consistent with this Plan and with ERISA, as necessary
and appropriate in carrying out his or her responsibilities in reviewing benefit claims. The Plan Administrator may require an applicant
who wishes to submit additional information in connection with an appeal from the denial (or deemed denial) of benefits to do so at the
applicant’s own expense.

 

(f)             Exhaustion
of Remedies. No legal action for benefits under this Plan may be brought until the claimant (i) has submitted a written application
for benefits in accordance with the procedures described by Section 15(a) above, (ii) has been notified by the Plan Administrator
that the application is denied (or the application is deemed denied due to the Plan Administrator’s failure to act on it within
the established time period), (iii) has filed a written request for a review of the application in accordance with the appeal procedure
described in Section 15(c) above and (iv) has been notified in writing that the Plan Administrator has denied the appeal
(or the appeal is deemed to be denied due to the Plan Administrator’s failure to take any action on the claim within the time prescribed
by Section 15(d) above).

 

16.           Indemnification.
To the extent permitted by law, the Plan Administrator and all employees, officers, directors, agents and representatives of the Company
shall be indemnified by the Company and held harmless against any claims and all associated expenses of defending against such claims,
resulting from any action or conduct relating to the administration of this Plan, whether as a member of the Committee or otherwise, except
to the extent that such claims arise from gross negligence, willful neglect, or willful misconduct. The Company shall advance all expenses
for which a party is indemnified under this Section 16 to such indemnified party or shall arrange for direct payment of any such
expenses by the Company.

 

    9

     

    

 

17.           Plan
Not an Employment Contract.  This Plan is not a contract between the Company and any employee, nor is it a condition of employment
of any employee. Nothing contained in this Plan gives, or is intended to give, any employee the right to be retained in the service of
the Company, or to interfere with the right of the Company to discharge or terminate the employment of any employee at any time and for
any reason. No employee shall have the right or claim to benefits beyond those expressly provided in this Plan, if any. All rights and
claims are limited as set forth in this Plan.

 

18.           Severability.
In case any one or more of the provisions of this Plan (or part thereof) shall be held to be invalid, illegal or unenforceable in any
respect, such invalidity, illegality or unenforceability shall not affect the other provisions hereof, and this Plan shall be construed
as if such invalid, illegal or unenforceable provisions (or part thereof) never had been contained herein.

 

19.           Non
Assignability.  No right or interest of any Participant in this Plan shall be assignable or transferable in whole or in part either
directly or by operation of law or otherwise, including, but not limited to, execution, levy, garnishment, attachment, pledge or bankruptcy.

 

20.           Integration
With Other Pay or Benefits Requirements. The severance payments and benefits provided for in this Plan are the maximum benefits
that the Company will pay to Participants on a termination of employment, except to the extent otherwise required by applicable law. To
the extent that any federal, state or local law, including, without limitation, so called “plant closing” laws, requires the
Company to give advance notice or make a payment of any kind to an employee because of that employee’s involuntary termination due
to a layoff, reduction in force, plant or facility closing, sale of business, or similar event, the benefits provided under this Plan
or the other arrangement shall either be reduced or eliminated to avoid any duplication of payment. The Company intends for the benefits
provided under this Plan to partially or fully satisfy any and all statutory obligations that may arise out of an employee’s involuntary
termination for the foregoing reasons and the Company shall so construe and implement the terms of this Plan.

 

21.           Amendment
or Termination.  The Board may amend, modify, or terminate this Plan at any time in its sole discretion; provided, however, that:
(a) any such amendment, modification or termination made prior to a Change in Control that adversely affects the rights of any Participant
shall be approved by the Company’s Board of Directors; (b) no such amendment, modification or termination may adversely affect
the rights of a Participant then receiving payments or benefits under this Plan without the consent of such person; and (c) no such
amendment, modification or termination made after a Change in Control shall be effective until after the later to occur of the first (1st)
anniversary of the Change in Control or the final payment of benefits under this Plan to any Participant. The Board intends to review
this Plan at least annually.

 

22.           Source
of Benefit. The Company will pay benefits under the Plan from its general assets to the extent available. The benefits are not
funded through a trust fund or insurance contracts. No employee shall have any right to, or interest in, any assets of the Company upon
termination of employment or otherwise.

 

    10

     

    

 

23.          Statement
of ERISA Rights. Participants are entitled to certain rights and protections under the Employee Retirement Income Security Act
of 1974, as amended (“ERISA”). ERISA provides that Participants are entitled to the following rights:

 

(a)             Receive
Information About the Plan and Benefits. A Participant may examine, without charge, at the Plan Administrator’s office all documents
governing the Plan and, if applicable, a copy of the latest annual report (Form 5500) filed with the U.S. Department of Labor and
available at the Public Disclosure Room of the Employee Benefits Security Administration. A Participant may also obtain copies of these
documents upon written request to the Plan Administrator. There may be a reasonable charge for the cost of copying. A Participant is also
entitled to receive a summary of the Plan’s annual financial report. The Plan Administrator is required by law to furnish each Participant
with a copy of this summary annual report.

 

(b)            Prudent
Actions by Plan Fiduciaries. In addition to creating rights for Plan participants, ERISA imposes duties upon the people who are responsible
for the operation of the Plan. The people who operate the Plan, called “fiduciaries,” have a duty to do so prudently and in
the interest of the Plan’s Participants and their beneficiaries. No one, including the Company, may fire a Participant or otherwise
discriminate against a Participant in any way to prevent the Participant from obtaining a welfare benefit or exercising the Participant’s
rights under ERISA.

 

(c)             Enforce
Participant Rights. If a Participant’s claim for a welfare benefit is denied or ignored, in whole or in part, the Participant
has the right to know the reason and to obtain copies of documents relating to the decision without charge, and to appeal any denial,
all within certain timeframes as set forth in this Plan. Under ERISA, there are steps a Participant can take to enforce the above rights.
For instance, if a Participant requests a copy of Plan documents, or the latest annual report from the Plan and the Participant does not
receive them within 30 days, the Participant may file suit in a federal court. In such a case, the court may require the Plan Administrator
to provide the materials to the Participant and pay the Participant up to $110 per day until the Participant receives the materials, unless
the materials were not sent because of reasons beyond the control of the Plan Administrator. If the Participant has a claim for benefits
that is denied or ignored, in whole or in part, the Participant may file suit in federal or state court, provided the Participant has
exhausted the Plan’s administrative remedies (i.e. claims procedures). If it should happen that the Plan fiduciaries misuse the
Plan’s money, or if a Participant is discriminated against for asserting the Participant’s rights under this Plan or under
ERISA, the Participant may seek assistance from the U.S. Department of Labor, or may file suit in federal court. The court will decide
who should pay court costs and legal fees. If a Participant is successful, the court may order the person that the Participant sued to
pay these costs and fees. If a Participant loses, the court may order the Participant to pay these costs and fees if it finds the Participant’s
claim is frivolous.

 

(d)            Assistance
With Questions. If a Participant has any questions about the Plan, the Participant should contact the Plan Administrator. If a Participant
has questions about this statement or about the Participant’s rights under ERISA, the Participant should contact the nearest office
of the Employee Benefits Security Administration, U.S. Department of Labor, listed in your telephone directory or the Division of Participant
Assistance and Communications, Employee Benefits Security Administration, U.S. Department of Labor, 200 Constitution Avenue, N.W., Washington,
D.C. 20210. The Participant may obtain publications about the Participant’s rights and responsibilities under ERISA by calling the
publications hotline of the Employee Benefits Security Administration. A Participant may also access the Employee Benefits Security Administration’s
website at www.dol.gov/ebsa.

 

24.           Type
of Plan. This Plan is a severance pay Plan.

 

    11

     

    

 

25.           Plan
Sponsor. The sponsor of this Plan is Hyperfine, Inc. (referred to in this Plan as the “Company”). The Plan sponsor’s
address is:

 

Hyperfine, Inc.

531 New Whitfield Street

Guilford, CT 06437

Attention: Chief People Officer

administrator@hyperfine.io

 

26.           Agent
for Legal Process. A Participant or beneficiary may serve legal process on the Plan Administrator, c/o:

 

Hyperfine, Inc.

531 New Whitfield Street

Guilford, CT 06437

Attention: Chief People Officer

 

With a copy to:

 

Hyperfine, Inc.

531 New Whitfield Street

Guilford, CT 06437

Attention: legal@hyperfine.io

 

27.           Plan
Year. The Plan Year is the calendar year.

 

28.           Identification
Number. The Plan’s number for purposes of discussion with a federal government agency is 501. The Company's Employer Identification
Number is 98-1569027.

 

29.           Summary
Plan Description. This Plan constitutes both the governing document and the summary plan description for the Plan.

 

30.           Governing
Law. This Plan and the rights of all persons under this Plan shall be construed in accordance with and under applicable provisions
of ERISA, and the regulations thereunder, and the laws of the State of Delaware (without regard to conflict of law provisions) to the
extent not preempted by federal law.

 

    12

     

    

 

EXHIBIT A

MULTIPLIERS

 

	Title/Role of Participant	 	Normal Multiplier	 	CIC Multiplier
	Executive Vice Presidents and Senior Vice
    Presidents	 	1.0	 	1.0
	Vice Presidents	 	0.5	 	0.75

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}]]